While Context Therapeutics Inc has underperformed by -4.39%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CNTX rose by 3.81%, with highs and lows ranging from $1.65 to $0.49, whereas the simple moving average jumped by 28.02% in the last 200 days.
On September 18, 2025, Guggenheim started tracking Context Therapeutics Inc (NASDAQ: CNTX) recommending Buy. A report published by William Blair on April 21, 2025, Initiated its previous ‘Outperform’ rating for CNTX. JMP Securities also rated CNTX shares as ‘Mkt Outperform’, setting a target price of $4 on the company’s shares in an initiating report dated January 08, 2025. D. Boral Capital Initiated an Buy rating on November 25, 2024, and assigned a price target of $9. Piper Sandler initiated its ‘Overweight’ rating for CNTX, as published in its report on May 16, 2024.
Analysis of Context Therapeutics Inc (CNTX)
To gain a thorough understanding of Context Therapeutics Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -33.68% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 13.07, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and CNTX is recording an average volume of 293.63K. On a monthly basis, the volatility of the stock is set at 8.82%, whereas on a weekly basis, it is put at 11.02%, with a loss of -6.03% over the past seven days. Furthermore, long-term investors anticipate a median target price of $5.33, showing growth from the present price of $1.09, which can serve as yet another indication of whether CNTX is worth investing in or should be passed over.
How Do You Analyze Context Therapeutics Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 34.43%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 43.09% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
